Financials
- Market Capitalization 43.72 B
- Employee 11 K
- Founded 1983
- CEO Jay Mazelsky
- Website www.idexx.com
- Headquarter Delaware, United States
- FIGI BBG000BLRT07
- Industry Diagnostics & Research
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 107 | DHR Danaher Corporation Common Stock | 216.06 USD | +0.13% | -0.57% | +10.85% | +5.54% | 151.89 B USD | ||
| 338 | NTRA Natera, Inc. - Common Stock | 326.26 USD | -3.67% | -0.65% | +29.27% | +96.47% | 47.03 B USD | ||
| 364 | A Agilent Technologies, Inc. Common Stock | 153.77 USD | -2.36% | -1.56% | +10.36% | +24.16% | 43.43 B USD | ||
| 367 | IQV IQVIA Holdings, Inc. Common Stock | 261.73 USD | -0.21% | +1.94% | +7.27% | +38.40% | 43.08 B USD |
Frequently asked questions about Idexx Laboratories Inc
What is the Idexx Laboratories Inc stock price today?
The current price of Idexx Laboratories Inc (IDXX) is 554.99. Over the past 24 hours, the stock has changed by +1.82%. Follow the IDXX chart for real-time price dynamics.
What is the stock ticker of Idexx Laboratories Inc?
Idexx Laboratories Inc trades under the ticker IDXX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Idexx Laboratories Inc stock going up?
IDXX has changed by -0.72% over the last week, -1.24% over the last month, and -12.88% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Idexx Laboratories Inc?
Idexx Laboratories Inc currently has a market capitalization of 43.72 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Idexx Laboratories Inc earnings last quarter?
Last quarter, Idexx Laboratories Inc reported earnings of 4.29 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Idexx Laboratories Inc revenue for the last quarter?
Idexx Laboratories Inc reported quarterly revenue of 1.21 B. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Idexx Laboratories Inc net income for the last quarter?
Idexx Laboratories Inc reported net income of 338.41 M for the last quarter. The previous quarter showed 278.45 M, which means net income changed by +21.54%.
How many employees does Idexx Laboratories Inc have?
As of the latest available data, Idexx Laboratories Inc has 11 K employees. Workforce size can provide additional context about the company's scale and operations.
What is Idexx Laboratories Inc EBITDA?
Idexx Laboratories Inc EBITDA is 461.95 M, and its EBITDA margin is 38.04%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Idexx Laboratories Inc stock?
You can buy Idexx Laboratories Inc (IDXX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Idexx Laboratories Inc stock?
Investing in Idexx Laboratories Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IDXX chart and related analysis on metatrader.com as part of your research.